Aptima®

We have partnered with Hologic's Aptima® platform to provide an extensive menu of FDA approved assays.

HPV 16, 18/45 Genotype:  The Aptima® HPV assay targets E6/E7 mRNA and identifies high-risk HPV infections that are present and active.

CT/NG: Chlamydia and Gonorrhea are often asymptomatic infections.  A recent study estimated that 45% of tubal factor infertility cases were caused by chlamydia infections.

Mycoplasma Genitalium: M.gen can be difficult to detect because the bacterial organism load is low compared to other STIs commonly tested for.  This means that a highly sensitive rRNA test is needed for accurate diagnosis.

Trichomonas Vaginalis:  The Aptima TV assay has been shown to be 97% sensitive for the detection of Trichomonas vaginalis.  As part of the CV/TV assay, the specificity range is 95-99% by collection device.

Bacterial Vaginosis:  The Aptima® BV assay provides a clear diagnosis for BV with a high sensitivity of 95-97% and specificity of 86-90%.  The assay targets three indicators of the vaginal microbiome: Lactobacillus, G. vaginalis, and A. vaginae.

Candida Vaginitis:  The assay qualitatively reports Candida species group (C. albicans, C. tropicalis, C. parapsilosis, and C. dubliniensis) and Candida glabrata.  The assay has a sensitivity of 85-93% and specificity of 91-99%.

Review our requisition for a complete list of the Women's Health services that we provide.